Therefore, the reduction of oxidative/inflammatory transcription factors in T2D would not only limit tissue insults but also decrease the oxidative destruction of a wide variety of important metabolic regulators including adiponectin and insulin [100, 102]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.